CLINICAL_TRIALS
research
· 2025-11-06
Clinical Trial Update: A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol [Phase 2]
Summary
A Phase 2 mechanistic study investigating MAR001 in adults with elevated triglycerides and remnant cholesterol is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Marea Therapeutics | Conditions: Hypertriglyceridemia | Phase 2 | Status: RECRUITING